scholarly journals Radionuclide therapy targeting PSMA for the treatment of metastatic prostate cancer: Current point of view and ways of improvement

2019 ◽  
Vol 43 (3) ◽  
pp. 275-279
Author(s):  
A.L. Giraudet
Keyword(s):  
Prostate Cancer ◽  
Radionuclide Therapy ◽  
Metastatic Prostate Cancer ◽  
Point Of View ◽  
Current Point

uPAR Targeted Radionuclide Therapy with177Lu-DOTA-AE105 Inhibits Dissemination of Metastatic Prostate Cancer

2014 ◽  
Vol 11 (8) ◽  
pp. 2796-2806 ◽  
Author(s):  
Morten Persson ◽  
Karina Juhl ◽  
Palle Rasmussen ◽  
Malene Brandt-Larsen ◽  
Jacob Madsen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radionuclide Therapy ◽  
Metastatic Prostate Cancer ◽  
Targeted Radionuclide Therapy

Radionuclide Therapy of Metastatic Prostate Cancer

2019 ◽  
Vol 49 (4) ◽  
pp. 313-325 ◽  
Author(s):  
Clemens Kratochwil ◽  
Uwe Haberkorn ◽  
Frederik L. Giesel
Keyword(s):  
Prostate Cancer ◽  
Radionuclide Therapy ◽  
Metastatic Prostate Cancer

Theranostics of Metastatic Prostate Cancer Applying 64Cu/18F/68Ga PSMA PET-CT and 177Lu Radiopharmaceuticals

2020 ◽  
Vol 13 ◽  
Author(s):  
Siroos Mirzaei ◽  
Fairoz Mohammed ◽  
Shahin Zandieh
Keyword(s):  
Prostate Cancer ◽  
Nuclear Medicine ◽  
Radionuclide Therapy ◽  
Metastatic Prostate Cancer ◽  
Therapy Response ◽  
Radioligand Therapy ◽  
Psma Pet ◽  
Pet Ct ◽  
Diagnostic Sensitivity And Specificity ◽  
Tumor Types

: The successful use of theranostic twins in neuroendocrine tumors (NET) was the pioneering approach to radionuclide therapy in other tumor types. 64Cu/18F PSMA for molecular imaging with PET-CT and peptide radioligand therapy (PRLT) with 177Lu labeled PSMA inhibitors are the next theranostic twins in nuclear medicine. 68Ga/ 64Cu/18F PSMA PET-CT detects metastatic prostate cancer with high diagnostic sensitivity and specificity and can be used to select patients for PRLT and evaluate therapy response. Radionuclide therapy with 177Lu-PSMA inhibitors has been shown to be effective in the treatment of metastatic CRPC.

646: 25-Year Outcomes of Radical Prostatectomy for the Treatment of All Stages of Non-Metastatic Prostate Cancer

2006 ◽  
Vol 175 (4S) ◽  
pp. 208-208
Author(s):  
Brant A. Inman ◽  
Jeffrey M. Slezak ◽  
Eugene D. Kwon ◽  
Robert P. Myers ◽  
Bradley C. Leibovich ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Metastatic Prostate Cancer
Sign in / Sign up

Export Citation Format

Share Document